GeneReach Biotechnology Corp. (TPEX:4171)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
22.90
+0.15 (0.66%)
Jun 18, 2025, 2:31 PM CST

GeneReach Biotechnology Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-108.81-118.73-166.27221.34376.62257.28
Upgrade
Depreciation & Amortization
71.8773.7368.0364.2859.2451.33
Upgrade
Other Amortization
1.091.010.860.890.770.5
Upgrade
Loss (Gain) From Sale of Assets
27.9428.171.39-1.7-0.41-0.5
Upgrade
Loss (Gain) From Sale of Investments
-2.712.572.53.73.815.19
Upgrade
Loss (Gain) on Equity Investments
-----0.04
Upgrade
Provision & Write-off of Bad Debts
-4.2-4.6521.43-1.135.061.99
Upgrade
Other Operating Activities
-6.66-1.35-66.17-65.6114.858.93
Upgrade
Change in Accounts Receivable
-15.22-16.9712.04138.08-31.15-93.49
Upgrade
Change in Inventory
5.9514.8124.5916.07-91.29-156.1
Upgrade
Change in Accounts Payable
1.571.39-0.24-6.04-5.444.55
Upgrade
Change in Unearned Revenue
1.44-0.55-2.84-11.4913.17-
Upgrade
Change in Other Net Operating Assets
4.39-2.63-33.99-0.733.8240.1
Upgrade
Operating Cash Flow
-23.34-23.22-38.67357.63348.99169.82
Upgrade
Operating Cash Flow Growth
---2.48%105.51%-
Upgrade
Capital Expenditures
-6.44-7.12-23.53-49.87-19.56-62.2
Upgrade
Sale of Property, Plant & Equipment
0.540.17-3.931.970.82
Upgrade
Sale (Purchase) of Intangibles
-3.07-1.34-3.82-0.59-1.36-2.67
Upgrade
Investment in Securities
-43.83-62.75-221.54-3.85-
Upgrade
Other Investing Activities
0.750.84-1.02-1.48-26.61-44.85
Upgrade
Investing Cash Flow
-52.05-70.21-249.91-48.01-41.7-108.9
Upgrade
Short-Term Debt Issued
-13755--51
Upgrade
Long-Term Debt Issued
----19830
Upgrade
Total Debt Issued
9813755-19881
Upgrade
Short-Term Debt Repaid
--70---2-
Upgrade
Long-Term Debt Repaid
--47.58-201.94-19.35-8.82-5.95
Upgrade
Total Debt Repaid
-117.46-117.58-201.94-19.35-10.82-5.95
Upgrade
Net Debt Issued (Repaid)
-19.4619.42-146.94-19.35187.1875.05
Upgrade
Common Dividends Paid
----208.94-143.67-
Upgrade
Other Financing Activities
-16.01-15.99-68.95--0.04-
Upgrade
Financing Cash Flow
-35.473.43-215.89-228.2843.4875.05
Upgrade
Foreign Exchange Rate Adjustments
-20.4-16.5-27.373.84-1.010.69
Upgrade
Net Cash Flow
-131.26-106.5-531.8485.18349.75136.66
Upgrade
Free Cash Flow
-29.79-30.35-62.21307.76329.43107.62
Upgrade
Free Cash Flow Growth
----6.58%206.11%-
Upgrade
Free Cash Flow Margin
-13.98%-14.70%-27.59%41.03%32.55%12.56%
Upgrade
Free Cash Flow Per Share
-0.52-0.53-1.085.195.621.87
Upgrade
Cash Interest Paid
6.285.544.564.585.263.82
Upgrade
Cash Income Tax Paid
7.985.414.03117.3978.321.84
Upgrade
Levered Free Cash Flow
-13.55-68.7522.55262.91331.2546.48
Upgrade
Unlevered Free Cash Flow
-9.56-65.0426.15267.04335.1648.86
Upgrade
Change in Net Working Capital
4.949.3-127.92-101.55.4160.23
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.